Respiratory medical societies and the threat of bioterrorism

Thorax

Volumn 59, Issue 3, 2004, Pages 265-267

  O'Riordan, T G ^a   Smaldone, G C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ANTHRAX; BIOLOGICAL WARFARE; DATA BASE; EMERGENCY TREATMENT; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH PROMOTION; HOSPITAL SERVICE; HUMAN; INFORMATION PROCESSING; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; PANIC; PRIORITY JOURNAL; RESPIRATORY CARE; REVIEW; SOCIAL PROBLEM; THREAT;

BIOLOGICAL WARFARE; BIOTERRORISM; CIVIL DEFENSE; DISASTER PLANNING; EDUCATION, MEDICAL, CONTINUING; EMERGENCY MEDICAL SERVICES; HEALTH POLICY; HUMANS; PANIC; PUBLIC HEALTH ADMINISTRATION; PULMONARY DISEASE (SPECIALTY); SOCIETIES, MEDICAL;

EID: 1542719747     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.2003.015321     Document Type: Review

References (16)

1. Bush LM, Abrams BH, Beall A, et al. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001;345:1607-10.
2. Hughes JM, Gerberding JL. Anthrax bioterrorism: lessons learned and future directions. Emerg Infect Dis 2002;8:1013-4.
3. Perkins BA, Popovic T, Yeskey K. Public health in the time of bioterrorism. Emerg Infect Dis 2002;8:1015-7.
4. Jones J, Terndrup TE, Franz DR, et al. Future challenges in preparing for and responding to bioterrorism events. Emerg Med Clin North Am 2002;20:501-24.
5. Darling RG, Catlett CL, Huebner KD, et al. Threats in bioterrorism. I: CDC category A agents. Emerg Med Clin North Am 2002;20:273-309.
6. Moran GJ. Threats In Bioterrorism II: CDC Category B and C agents. Emerg Med Clin North Am 2002;20:311-36.
7. Pavlin JA, Mostashari F, Kortepeter MG, et al. Innovative surveillance methods for rapid detection of disease outbreaks and bioterrorism: results of an interagency workshop on health indicator surveillance. Am J Public Health 2003;9:1230-5.
8. Kline CR Jr. High-speed advanced sensors for bioterror weapons. What we have done, what more needs to be done now, and what need's to be done in the future. IEEE Engineering Medicine & Biology Magazine 2002;21:43-7.
9. Garrett L. Betrayal of trust: the collapse of global public health. New York: Hyperion, 2000.
10. Johns Hopkins Center for Civilian Biodefense. Dark winter. www.hopkins-biodefense.org/darkwinter.html.
11. Esbitt D. The strategic national stockpile: roles and responsibilities of health care professionals for receiving the stockpile assets. Disaster Manag Response 2003;1:68-70.
12. Karwa M, Bronzert P, Kvetan V. Bioterrorism and critical care. Crit Care Clin 2003;19:279-313.
13. Callahan JD, Brown F, Osorio FA, et al. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J Am Vet Med Assoc 2002;220:1636-42.
14. Risatti GR, Callahan JD, Nelson WM, et al. Rapid detection of classical swine fever virus by a portable real-time reverse transcriptase PCR assay. J Clin Microbiol 2003;41:500-5.
15. Baltimore RS, McMillan JA. Smallpox and the smallpox vaccine controversy. Pediatr Infect Dis J 2002;21:789-90.
16. Alibek K, Handelsman S. Biohazard. New York: Dell Publishing, 1999.